Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not a discussion board

Fut's right -- in fact the company "paid" S&L 7 million warrants to agree to the debenture conversion.

Best regards.

Share
New Message
Please login to post a reply